Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-03-01 @ 10:02 AM
Study NCT ID:
NCT03930004
Status:
COMPLETED
Last Update Posted:
2019-10-08
First Post:
2019-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
Sponsor:
Roberto Léo da Silva
Organization:
Study Overview
Official Title:
Preclinical Cardiomyopathy in Type 1 Diabetes: Correlation With Autonomic Dysfunction
Status:
COMPLETED
Status Verified Date:
2019-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Type 1 diabetes mellitus is a chronic autoimmune disease, associated with an increased risk of cardiovascular diseases. The development of cardiomyopathy in type 1 diabetes, independent of hypertension and coronary heart disease, is still controversial. A possible mechanism for diabetic cardiomyopathy is autonomic dysfunction. This study aims to evaluate cardiac function and structure, and to relate them with autonomic dysfunction in type 1 diabetes.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: